Colgate-Palmolive (NYSE:CL) Shares Sold by Kore Private Wealth LLC

Kore Private Wealth LLC trimmed its position in shares of Colgate-Palmolive (NYSE:CL) by 5.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,977 shares of the company’s stock after selling 215 shares during the quarter. Kore Private Wealth LLC’s holdings in Colgate-Palmolive were worth $324,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Horan Securities Inc. increased its stake in shares of Colgate-Palmolive by 60.1% during the second quarter. Horan Securities Inc. now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 128 shares during the period. Cowen Prime Advisors LLC acquired a new position in Colgate-Palmolive during the second quarter worth about $28,000. Perennial Advisors LLC acquired a new position in Colgate-Palmolive during the second quarter worth about $28,000. Eagle Bay Advisors LLC acquired a new position in Colgate-Palmolive during the second quarter worth about $32,000. Finally, First PREMIER Bank acquired a new position in Colgate-Palmolive during the second quarter worth about $33,000. Institutional investors and hedge funds own 76.28% of the company’s stock.

In other Colgate-Palmolive news, Director Lorrie M. Norrington sold 1,898 shares of the stock in a transaction that occurred on Wednesday, August 4th. The shares were sold at an average price of $78.02, for a total transaction of $148,081.96. Following the transaction, the director now owns 24,602 shares of the company’s stock, valued at $1,919,448.04. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 20,290 shares of the stock in a transaction that occurred on Thursday, August 5th. The stock was sold at an average price of $79.11, for a total transaction of $1,605,141.90. The disclosure for this sale can be found here. Insiders have sold 22,798 shares of company stock worth $1,800,304 in the last three months. Insiders own 0.32% of the company’s stock.

Several brokerages have weighed in on CL. UBS Group began coverage on shares of Colgate-Palmolive in a research report on Wednesday, June 23rd. They set a “buy” rating and a $95.00 target price on the stock. Bank of America began coverage on shares of Colgate-Palmolive in a research report on Tuesday, October 5th. They set a “neutral” rating on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their target price for the stock from $84.00 to $86.00 in a research report on Monday, September 20th. Finally, Evercore ISI reaffirmed a “buy” rating and issued a $95.00 price target on shares of Colgate-Palmolive in a report on Sunday, June 20th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $85.69.

Shares of CL opened at $76.07 on Thursday. The company has a debt-to-equity ratio of 9.22, a quick ratio of 0.70 and a current ratio of 1.11. The company has a market capitalization of $64.17 billion, a price-to-earnings ratio of 23.85, a PEG ratio of 3.98 and a beta of 0.60. The company’s 50 day simple moving average is $77.27 and its 200 day simple moving average is $80.23. Colgate-Palmolive has a 1 year low of $74.01 and a 1 year high of $86.41.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Thursday, July 29th. The company reported $0.80 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.80. The business had revenue of $4.26 billion for the quarter, compared to the consensus estimate of $4.24 billion. Colgate-Palmolive had a net margin of 15.98% and a return on equity of 293.48%. The company’s quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.74 earnings per share. Equities analysts expect that Colgate-Palmolive will post 3.23 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 15th. Investors of record on Thursday, October 21st will be paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.37%. The ex-dividend date of this dividend is Wednesday, October 20th. Colgate-Palmolive’s payout ratio is 58.82%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.

Further Reading: What are the risks of holding treasury bonds?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.